Detalles de la búsqueda
1.
Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancy.
Support Care Cancer
; 31(3): 167, 2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36781558
2.
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Cancer Immunol Immunother
; 71(5): 1157-1165, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618180
3.
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 19(8): 915-921, 2021 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878726
4.
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.
Cancer Immunol Immunother
; 69(11): 2403-2408, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728772
5.
Improving Access to Early Palliative Care Delivery for Patients With an Advanced Thoracic Malignancy Through an Embedded Oncopalliative Clinic Model.
JCO Oncol Pract
; 19(9): 777-785, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279410
6.
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
J Cancer Res Clin Oncol
; 149(5): 2235-2242, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36070148
7.
Podcast on the Management of Adverse Events Associated with Lorlatinib.
Adv Ther
; 39(4): 1447-1456, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35147918
8.
Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy.
Front Oncol
; 12: 835881, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35295997
9.
Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNA.
Lung Cancer
; 165: 43-48, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085983
10.
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.
Clin Lung Cancer
; 23(4): 345-355, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131184
11.
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges.
Clin Cancer Res
; 28(12): 2506-2516, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35091443
12.
Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care.
J Pain Palliat Care Pharmacother
; 35(2): 91-99, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34010103
13.
Too Many Appointments: Assessing Provider and Nursing Perception of Barriers to Referral for Outpatient Palliative Care.
Palliat Med Rep
; 2(1): 137-145, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34223513
14.
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Clin Lung Cancer
; 22(4): e519-e527, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33414052
15.
Advances in epigenetic therapeutics with focus on solid tumors.
Clin Epigenetics
; 13(1): 83, 2021 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33879235
16.
Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903).
Clin Cancer Res
; 27(6): 1604-1611, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33376097
17.
Second cancer incidence in CLL patients receiving BTK inhibitors.
Leukemia
; 34(12): 3197-3205, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32704159
18.
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer.
Lung Cancer
; 134: 167-173, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319977
19.
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 5(10): 1448-1455, 2019 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31393548
20.
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
J Cancer Res Clin Oncol
; 145(10): 2541-2546, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31367835